Bioharvest Sciences Inc. SEC filings BHST
Bioharvest Sciences Inc. has 136 filings in SEC EDGAR's recent list, going back to Nov 24, 2017. Its latest annual report, Form 40-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Post-effective amendment no. 1 to form f-3 | Dec 29, 2025 | — |
| 424B5 | Prospectus supplement | Nov 10, 2025 | — |
| 424B7 | Prospectus supplement no. 3 | Nov 6, 2025 | — |
| 424B7 | Prospectus supplement no. 2 | Oct 15, 2025 | — |
| 424B7 | Prospectus supplement no. 1 | Sep 24, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 28, 2025 | — |
| S-8 | Employee stock plan registration | Jul 23, 2025 | — |
| F-X | Appointment of agent for service of process and undertaking | Mar 31, 2025 | — |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BHST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1723464
- Former names
- CANNA-V-CELL SCIENCES INC. (until Apr 21, 2020); Midnight Star Ventures Corp. (until Oct 15, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.